Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
INACTIVE
Global HQ
China
Countries of investment
  • USA
  • China
Investment stages
  • Seed
Industries
  • HealthCare
About
3E Bioventures Capital is a dedicated healthcare-focused fund investing in cutting-edge life sciences and biomedical technologies. Specializing in innovative therapeutic drugs and disruptive cross-disciplinary med tech, the company collaborates closely with startups to advance healthcare breakthroughs.
Min check size
$1M
Max check size
$5M
Fund size
NPS

Investment Thesis

3E Bioventures is dedicated to capitalizing on the significant growth potential in the Chinese healthcare industry over the next 10 to 20 years. The firm aims to leverage its teams biomedical training and healthcare industry experience to support early and growthstage companies. By combining a global industry perspective with practical ontheground experience in China, 3E Bioventures seeks to build successful healthcare ventures and technologies that generate substantial returns for investors. The firm is committed to fostering innovation in the healthcare sector and establishing itself as a leading international healthcare investment brand.
Lead investor
Co Invest
Number of exits
Preferred contact method
Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp